Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 117(46): 28960-28970, 2020 11 17.
Article in English | MEDLINE | ID: mdl-33127761

ABSTRACT

Inhibition of the chemokine receptor CXCR4 in combination with blockade of the PD-1/PD-L1 T cell checkpoint induces T cell infiltration and anticancer responses in murine and human pancreatic cancer. Here we elucidate the mechanism by which CXCR4 inhibition affects the tumor immune microenvironment. In human immune cell-based chemotaxis assays, we find that CXCL12-stimulated CXCR4 inhibits the directed migration mediated by CXCR1, CXCR3, CXCR5, CXCR6, and CCR2, respectively, chemokine receptors expressed by all of the immune cell types that participate in an integrated immune response. Inhibiting CXCR4 in an experimental cancer medicine study by 1-wk continuous infusion of the small-molecule inhibitor AMD3100 (plerixafor) induces an integrated immune response that is detected by transcriptional analysis of paired biopsies of metastases from patients with microsatellite stable colorectal and pancreatic cancer. This integrated immune response occurs in three other examples of immune-mediated damage to noninfected tissues: Rejecting renal allografts, melanomas clinically responding to anti-PD1 antibody therapy, and microsatellite instable colorectal cancers. Thus, signaling by CXCR4 causes immune suppression in human pancreatic ductal adenocarcinoma and colorectal cancer by impairing the function of the chemokine receptors that mediate the intratumoral accumulation of immune cells.


Subject(s)
Colorectal Neoplasms/metabolism , Immunity/immunology , Pancreas/metabolism , Pancreatic Neoplasms/metabolism , Receptors, CXCR4/drug effects , Receptors, CXCR4/metabolism , Aged , Benzylamines , Carcinoma, Pancreatic Ductal , Chemokine CXCL12 , Colorectal Neoplasms/pathology , Cyclams , Female , Heterocyclic Compounds/antagonists & inhibitors , Humans , Immunotherapy , Male , Middle Aged , Pancreatic Neoplasms/pathology , Receptors, CCR2/metabolism , Receptors, CXCR3/metabolism , Receptors, CXCR5/metabolism , Receptors, CXCR6/metabolism , Receptors, Interleukin-8A/metabolism , Signal Transduction/drug effects , Tumor Microenvironment/immunology , Pancreatic Neoplasms
2.
Nat Commun ; 6: 6001, 2015 Jan 23.
Article in English | MEDLINE | ID: mdl-25613188

ABSTRACT

Mutations in the tricarboxylic acid (TCA) cycle enzyme fumarate hydratase (FH) are associated with a highly malignant form of renal cancer. We combined analytical chemistry and metabolic computational modelling to investigate the metabolic implications of FH loss in immortalized and primary mouse kidney cells. Here, we show that the accumulation of fumarate caused by the inactivation of FH leads to oxidative stress that is mediated by the formation of succinicGSH, a covalent adduct between fumarate and glutathione. Chronic succination of GSH, caused by the loss of FH, or by exogenous fumarate, leads to persistent oxidative stress and cellular senescence in vitro and in vivo. Importantly, the ablation of p21, a key mediator of senescence, in Fh1-deficient mice resulted in the transformation of benign renal cysts into a hyperplastic lesion, suggesting that fumarate-induced senescence needs to be bypassed for the initiation of renal cancers.


Subject(s)
Fumarates/chemistry , Glutathione/metabolism , Animals , Cell Line , Cell Proliferation , Cell Transformation, Neoplastic , Cellular Senescence , Chromatography, Liquid , Computational Biology , Female , Fibroblasts/metabolism , Fumarate Hydratase/chemistry , Glutamine/chemistry , Immunohistochemistry , Kidney/metabolism , Magnetic Resonance Spectroscopy , Male , Mass Spectrometry , Metabolomics , Mice , Mice, Inbred C57BL , Mutation , Oxidation-Reduction , Oxidative Stress , Transcriptome
SELECTION OF CITATIONS
SEARCH DETAIL
...